Protein/NN
kinase/NN
C/NN
and/CC
calcineurin/NN
synergize/VBP
to/TO
activate/VB
IkappaB/NN
kinase/NN
and/CC
NF-kappaB/NN
in/IN
T/NN
lymphocytes/NNS
./.

The/DT
nuclear/JJ
factor/NN
of/IN
kappaB/NN
(/(
NF-kappaB/NN
)/)
is/VBZ
a/DT
ubiquitous/JJ
transcription/NN
factor/NN
that/WDT
is/VBZ
key/JJ
in/IN
the/DT
regulation/NN
of/IN
the/DT
immune/JJ
response/NN
and/CC
inflammation/NN
./.
=====
T/NN
cell/NN
receptor/NN
(/(
TCR/NN
)/)
cross-linking/NN
is/VBZ
in/IN
part/NN
required/VBN
for/IN
activation/NN
of/IN
NF-kappaB/NN
,/,
which/WDT
is/VBZ
dependent/JJ
on/IN
the/DT
phosphorylation/NN
and/CC
degradation/NN
of/IN
IkappaBalpha/NN
./.
=====
By/IN
using/VBG
Jurkat/NN
and/CC
primary/JJ
human/JJ
T/NN
lymphocytes/NNS
,/,
we/PRP
demonstrate/VBP
that/IN
the/DT
simultaneous/JJ
activation/NN
of/IN
two/CD
second/JJ
messengers/NNS
of/IN
the/DT
TCR-initiated/JJ
signal/NN
transduction/NN
,/,
protein/NN
kinase/NN
C/NN
(/(
PKC/NN
)/)
and/CC
calcineurin/NN
,/,
results/VBZ
in/IN
the/DT
synergistic/JJ
activation/NN
of/IN
the/DT
IkappaBalpha/NN
kinase/NN
(/(
IKK/NN
)/)
complex/NN
but/CC
not/RB
of/IN
another/DT
putative/JJ
IkappaBalpha/NN
kinase/NN
,/,
p90/NN
(/(
rsk/NN
)/)
./.
=====
We/PRP
also/RB
demonstrate/VBP
that/IN
the/DT
IKK/NN
complex/NN
,/,
but/CC
not/RB
p90/NN
(/(
rsk/NN
)/)
,/,
is/VBZ
responsible/JJ
for/IN
the/DT
in/FW
vivo/FW
phosphorylation/NN
of/IN
IkappaBalpha/NN
mediated/VBN
by/IN
the/DT
co-activation/NN
of/IN
PKC/NN
and/CC
calcineurin/NN
./.
=====
Each/DT
second/JJ
messenger/NN
is/VBZ
necessary/JJ
,/,
as/IN
inhibition/NN
of/IN
either/DT
one/CD
reverses/VBZ
the/DT
activation/NN
of/IN
the/DT
IKK/NN
complex/NN
and/CC
IkappaBalpha/NN
phosphorylation/NN
in/FW
vivo/FW
./.
=====
Overexpression/NN
of/IN
dominant/JJ
negative/JJ
forms/NNS
of/IN
IKKalpha/NN
and/CC
-beta/NN
demonstrates/VBZ
that/IN
only/JJ
IKKbeta/NN
is/VBZ
the/DT
target/NN
for/IN
PKC/NN
and/CC
calcineurin/NN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
within/IN
the/DT
TCR/CD3/NN
signal/NN
transduction/NN
pathway/NN
both/CC
PKC/NN
and/CC
calcineurin/NN
are/VBP
required/VBN
for/IN
the/DT
effective/JJ
activation/NN
of/IN
the/DT
IKK/NN
complex/NN
and/CC
NF-kappaB/NN
in/IN
T/NN
lymphocytes/NNS
./.